Inventor
DABROS MARTA
US15 patents
⚠️ This page may combine multiple inventors who share the name “DABROS MARTA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERAVANCE BIOPHARMA R&D IP LLC
12 patentsUS10493077B2Dec 3, 2019
Fused imidazo-piperidine JAK inhibitor compound
THERAVANCE BIOPHARMA R&D IP LLC14 citations94
US10251874B2Apr 9, 2019
Crystalline forms of a JAK inhibitor compound
THERAVANCE BIOPHARMA R&D IP LLC23 citations93
US10308646B2Jun 4, 2019
Pyrimidine compound as JAK kinase inhibitor
THERAVANCE BIOPHARMA R&D IP LLC11 citations92
US10183942B2Jan 22, 2019
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC23 citations92
US10913740B2Feb 9, 2021
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC5 citations83
US10538513B2Jan 21, 2020
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
THERAVANCE BIOPHARMA R&D IP LLC4 citations83
US10392368B2Aug 27, 2019
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
THERAVANCE BIOPHARMA R&D IP LLC5 citations80
US11160810B2Nov 2, 2021
Fused imidazo-piperidine JAK inhibitor compound
THERAVANCE BIOPHARMA R&D IP LLC2 citations73
US10968205B2Apr 6, 2021
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
THERAVANCE BIOPHARMA R&D IP LLC1 citations72
US12172994B2Dec 24, 2024
Pyrimidine compound as JAK kinase inhibitor
THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US11814377B2Nov 14, 2023
Pyrimidine compound as JAK kinase inhibitor
THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US11718616B2Aug 8, 2023
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC0 citations62
BRISTOL MYERS SQUIBB CO
3 patentsUS9115054B2Aug 25, 2015
Tetrahydronaphthalenyl compounds useful as sipi agonists
BRISTOL MYERS SQUIBB CO13 citations89
US12577214B2Mar 17, 2026
Polymorphs of bis(fluoroalkyl)-1,4-benzodiazepinone compounds and uses thereof
BRISTOL MYERS SQUIBB CO0 citations60
US9920034B2Mar 20, 2018
Crystalline forms of a factor XIa inhibitor
BRISTOL MYERS SQUIBB CO0 citations51